Medicine Description schizoswab 1 mg
schizoswab 1 mg oral drobs is a medication that functions as an atypical antipsychotic. It works primarily by modulating the activity of neurotransmitters in the brain, particularly dopamine and serotonin. Aripiprazole acts as a partial agonist at the D2 dopamine receptor, which helps to stabilize dopamine levels, reducing psychotic symptoms. Simultaneously, it has a partial agonistic effect on the 5-HT1A serotonin receptor, contributing to its efficacy in mood stabilization. This unique mechanism allows schizoswab to alleviate symptoms of schizophrenia and mood disorders while minimizing the typical side effects associated with full dopamine antagonists.
Indications and Uses of schizoswab 1 mg oral drobs
- Schizophrenia
- Bipolar I disorder (manic and mixed episodes)
- Adjunctive treatment of major depressive disorder
- Irritability associated with autism spectrum disorder
- Tourette syndrome
Side Effects of schizoswab 1 mg oral drobs
- Weight gain
- Insomnia
- Nausea
- Dizziness
- Extrapyramidal symptoms
- Fatigue
- Restlessness
- Blurred vision
Storage and Handling
Store at room temperature, away from direct sunlight and moisture. Keep out of reach of children, and do not freeze the medication.
Patient Advice and Precautions
Regularly monitor weight and metabolic parameters during treatment. Advise patients to report any unusual mood changes or worsening of symptoms promptly. Caution against sudden discontinuation of the medication to avoid withdrawal symptoms. Inform patients about the potential for sedation and advise them not to operate heavy machinery until they know how the medication affects them.